Clinical Trial

Tissue Doppler Echocardiographic Assessment of Cardiac Function in Neonatal Sepsis

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
1. To assess myocardial function in neonates with sepsis using tissue doppler echocardiography. 2. To assess sepsis induced cardiac dysfunction. 3. To measure serum levels of sepsis markers (CBC,CRP,Blood culture) and cardiac troponin in neonatal sepsis. 4. To analyze the correlation between echocardiographic parameters and serum biomarkers. 5. To determine whether these echocardiographic techniques can serve as early predictors of cardiac involvement in neonatal sepsis.
Trial Details
NCT Number NCT07572916
Lead Sponsor Assiut University
Conditions Neonatal Sepsis, Markers
Enrollment 80 participants
Start Date 2026-05-01
Primary Completion 2028-05-01 (estimated)
Study Completion 2029-05-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-07